To identify the mechanism of GM-CSF upregulation after anti-VEGF treatment, mouse ovarian cancer HM-1 and ID8-Vegf cells and human ovarian cancer SKOV3 cells were cultured under hypoxic conditions. This evidence concerns the gene CSF2 and ovarian cancer.